{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:51:49Z","timestamp":1791046309080,"version":"4.1.0"},"reference-count":96,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2133\/dmpk.dmpk-11-rv-116","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T05:20:31Z","timestamp":1320124831000},"page":"132-141","source":"Crossref","is-referenced-by-count":34,"title":["A Recent Update of Pharmacogenomics in Drug-induced Severe Skin Reactions"],"prefix":"10.2133","volume":"27","author":[{"given":"Chun-Yu","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Ming","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Tsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0005","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of stevens-johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, stevens-johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch. Dermatol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nri819","article-title":"Cytotoxic t lymphocytes: All roads lead to death","volume":"2","author":"Barry","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00809.x","article-title":"Calcium influx and signaling in cytotoxic T-lymphocyte lytic granule exocytosis","volume":"231","author":"Pores-Fernando","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.cellbio.23.090506.123521","article-title":"Secretory mechanisms in cell-mediated cytotoxicity","volume":"23","author":"Stinchcombe","year":"2007","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0952-7915(03)00114-6","article-title":"Perforin and the granule exocytosis cytotoxicity pathway","volume":"15","author":"Catalfamo","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.smim.2003.09.003","article-title":"The role of the secretory immunological synapse in killing by cd8+ ctl","volume":"15","author":"Stinchcombe","year":"2003","journal-title":"Semin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0040","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in stevens-johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat. Med."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0045","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1469-445X.2000.02097.x","article-title":"The role of perforin in infections and tumour surveillance","volume":"85","author":"van den Broek","year":"2000","journal-title":"Exp. Physiol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.jid.5700001","article-title":"Cytotoxic t cells","volume":"126","author":"Andersen","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0166-2236(02)02154-9","article-title":"Cytotoxic t lymphocytes in autoimmune and degenerative cns diseases","volume":"25","author":"Neumann","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0060","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and stevens-johnson syndrome: A review","volume":"39","author":"Gerull","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic t-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0070","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/mol.63.3.732","article-title":"Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drugspecific t cell clones","volume":"63","author":"Naisbitt","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0075","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class i-restricted activation of cd8+ t cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0080","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2006.12.617","article-title":"Generation and characterization of antigen-specific cd4+, cd8+, and cd4+cd8+ t-cell clones from patients with carbamazepine hypersensitivity","volume":"119","author":"Wu","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0085","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted t-cell receptor use is crucial for carbamazepine-induced stevens-johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0090","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1586\/erv.10.132","article-title":"Cytolytic cd4(+) t cells in viral immunity","volume":"9","author":"Soghoian","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-381300-8.00005-8","article-title":"The many face-lifts of cd4 t helper cells","volume":"107","author":"Mucida","year":"2010","journal-title":"Adv. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.0105-2896.2009.00848.x","article-title":"Cd4+cd25+ regulatory t cells in autoimmune arthritis","volume":"233","author":"Oh","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2006.03.005","article-title":"Activation of t cells by carbamazepine and carbamazepine metabolites","volume":"118","author":"Wu","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1398-9995.2009.02180.x","article-title":"In vitro detection of cytotoxic t and nk cells in peripheral blood of patients with various drug-induced skin diseases","volume":"65","author":"Zawodniak","year":"2010","journal-title":"Allergy"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tox.2004.12.023","article-title":"Drug-induced exanthems","volume":"209","author":"Yawalkar","year":"2005","journal-title":"Toxicology"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.all.0000244792.95615.3a","article-title":"Interaction of keratinocytes with infiltrating lymphocytes in allergic eczematous skin diseases","volume":"6","author":"Wittmann","year":"2006","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0125","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory t cells in patients with severe drug eruptions: Timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","article-title":"Stevens-johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Borchers","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0135","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.4049\/jimmunol.165.7.3612","article-title":"Cd4 help-independent induction of cytotoxic cd8 cells to allogeneic p815 tumor cells is absolutely dependent on costimulation","volume":"165","author":"Zhan","year":"2000","journal-title":"J. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0145","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.biocel.2008.05.001","article-title":"Natural killer cells: Detectors of stress","volume":"40","author":"Luci","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2007.11.002","article-title":"Immune evasion of natural killer cells by viruses","volume":"20","author":"Jonji\u0107","year":"2008","journal-title":"Curr. Opin. Immunol."},{"issue":"213\u2013229","key":"10.2133\/dmpk.DMPK-11-RV-116_bb0155","article-title":"Human natural killer cells","volume":"46","author":"Bar\u00e3o","year":"1998","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0160","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"Cd56bright natural killer (nk) cells: An important nk cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.2006.00454.x","article-title":"Functional subsets of mouse natural killer cells","volume":"214","author":"Hayakawa","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02983234","article-title":"Biology and clinical impact of human natural killer cells","volume":"78","author":"Farag","year":"2003","journal-title":"Int. J. Hematol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0175","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1398-9995.2010.02459.x","article-title":"Natural killer-dendritic cell interaction in lymphocyte responses in hypersensitivity reactions to betalactams","volume":"65","author":"Chaves","year":"2010","journal-title":"Allergy"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.smim.2008.06.003","article-title":"The yin and yang of hla and kir in human disease","volume":"20","author":"Kulkarni","year":"2008","journal-title":"Semin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0185","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaci.2009.10.030","article-title":"Cd94\/nkg2c is a killer effector molecule in patients with stevens-johnson syndrome and toxic epidermal necrolysis","volume":"125","author":"Morel","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0190","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: A marker for stevens-johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0195","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"Hla-b*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0200","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of hla-b*5701, hla-dr7, and hla-dq3 and hypersensitivity to hiv-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Loncet"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0205","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"Hla-b*5701 genotype is a major determinant of drug-induced liver injury due to flucloxadllin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat. Genet."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genome-wide study identifies hla alleles associated with lumiracoxib-related liver injury","volume":"42","author":"Singer","year":"2010","journal-title":"Nat. Genet."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000087914","article-title":"Hla class i\/nk cell receptor interaction in early human decidua basalis: Possible functional consequences","volume":"89","author":"Rabot","year":"2005","journal-title":"Chem. Immunol. Allergy"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"Nkt cells: What's in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0225","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4049\/jimmunol.171.4.1775","article-title":"Nkt cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine nkt cells","volume":"171","author":"Kenna","year":"2003","journal-title":"J. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0230","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.4049\/jimmunol.171.5.2571","article-title":"Cd1d-restricted nkt cells express a chemokine receptor profile indicative of th1-type inflammatory homing cells","volume":"171","author":"Thomas","year":"2003","journal-title":"J. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0235","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.182.4.993","article-title":"Cd1-restricted cd4+ t cells in major histocompatibility complex class ii-deficient mice","volume":"182","author":"Cardell","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-5793(02)02509-7","article-title":"Presence of a novel subset of nkt cells bearing an invariant v(alpha)19.1-j(alpha)26 tcr alpha chain","volume":"516","author":"Shimamura","year":"2002","journal-title":"FEBS Lett."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0245","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1002\/eji.200939800","article-title":"Nkt cells: Friend or foe during viral infections?","volume":"39","author":"Diana","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0250","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1615\/CritRevImmunol.v23.i56.30","article-title":"Cd1d-mediated antigen presentation to natural killer t (nkt) cells","volume":"23","author":"Brutkiewicz","year":"2003","journal-title":"Crit. Rev. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0255","first-page":"251","article-title":"Nkt cells and autoimmune diseases: Unraveling the complexity","volume":"314","author":"Miyake","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/400_2009_11","article-title":"Role of nk cells and invariant nkt cells in multiple sclerosis","volume":"51","author":"Sakuishi","year":"2010","journal-title":"Results Probl. Cell Differ."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0265","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ni.1841","article-title":"Raising the nkt cell family","volume":"11","author":"Godfrey","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2006.05.101","article-title":"Toxicophores: Investigations in drug safety","volume":"226","author":"Williams","year":"2006","journal-title":"Toxicology"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0275","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of cd95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0280","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00008571-199406000-00005","article-title":"Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions","volume":"4","author":"Gaedigk","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0285","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/0006-2952(95)02009-8","article-title":"Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity","volume":"50","author":"Green","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0290","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1398-9995.2004.00625.x","article-title":"Specific serum ige levels and fcepsilonribeta genetic polymorphism in patients with penicillins allergy","volume":"59","author":"Qiao","year":"2004","journal-title":"Allergy"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0295","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.fpc.0000230409.00276.44","article-title":"Gene-gene interactions of il13 and il4ra variants in immediate allergic reactions to betalactam antibiotics","volume":"16","author":"Gu\u00e9ant-Rodriguez","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0300","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1398-9995.2006.01067.x","article-title":"Il-10 promoter and il4-ralpha gene snps are associated with immediate beta-lactam allergy in atopic women","volume":"61","author":"Guglielmi","year":"2006","journal-title":"Allergy"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.tpj.6500456","article-title":"Association of tumor necrosis factor-alpha -308g>a polymorphism with ige-mediated allergy to betalactams in an italian population","volume":"8","author":"Gu\u00e9ant-Rodriguez","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0310","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic t cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0315","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1067\/mai.2003.1507","article-title":"Characterization of drug-specific t cells in lamotrigine hypersensitivity","volume":"111","author":"Naisbitt","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0320","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-5699(98)80012-1","article-title":"Allergic and autoimmune reactions to xenobiotics: How do they arise?","volume":"19","author":"Griem","year":"1998","journal-title":"Immunol. Today"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0325","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/eji.1830270602","article-title":"Penicilloyl peptides are recognized as t cell antigenic determinants in penicillin allergy","volume":"27","author":"Padovan","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0330","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2332\/allergolint.55.17","article-title":"Pharmacological interaction of drugs with immune receptors: The p-i concept","volume":"55","author":"Pichler","year":"2006","journal-title":"Allergol. Int."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0335","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/mol.105.021576","article-title":"Transfection of drug-specific t-cell receptors into hybridoma cells: Tools to monitor drug interaction with t-cell receptors and evaluate cross-reactivity to related compounds","volume":"70","author":"Schmid","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0340","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00130832-200208000-00007","article-title":"Late-onset allergy-like reactions to x-ray contrast media","volume":"2","author":"Christiansen","year":"2002","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0345","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.158.3.1139","article-title":"Characterization of lidocaine-specific t cells","volume":"158","author":"Zanni","year":"1997","journal-title":"J. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0350","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.2010.03764.x","article-title":"Delayed drug hypersensitivity: Models of t-cell stimulation","volume":"71","author":"Adam","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0355","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"Direct, mhc-dependent presentation of the drug sulfamethoxazole to human alphabeta t cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000441","article-title":"Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome","volume":"5","author":"Yang","year":"2009","journal-title":"PLOS Comput. Biol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0365","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2009.10.031","article-title":"Stimulation of human t cells with sulfonamides and sulfonamide metabolites","volume":"125","author":"Castrejon","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0370","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1747.2000.00985.x","article-title":"A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions","volume":"114","author":"Reilly","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0375","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1124\/jpet.105.086009","article-title":"Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes","volume":"314","author":"Roychowdhury","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","article-title":"Blister fluid t lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (nk' inhibitory receptors","volume":"119","author":"Le Cleach","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0385","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2004.04.034","article-title":"Involvement of ccl27-ccr10 interactions in drug-induced cutaneous reactions","volume":"114","author":"Tapia","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0390","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced stevens-johnson syndrome is associated with hla-b*1502 allele in thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0395","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for stevens-johnson syndrome: Ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0400","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of hla-b*1502 allele and carbamazepine-induced stevens-johnson syndrome among indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0405","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":"Association between hla-b*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0410","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2007.06.017","article-title":"Hla-b*1502-bound peptides: Implications for the pathogenesis of carbamazepine-induced stevens-johnson syndrome","volume":"120","author":"Yang","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0415","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":"Hla-b*1511 is a risk factor for carbamazepine-induced stevens-johnson syndrome and toxic epidermal necrolysis in japanese patients","volume":"51","author":"Kaniwa","year":"2010","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0420","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":"Carbamazepine-induced severe cutaneous adverse reactions and hla genotypes in koreans","volume":"97","author":"Kim","year":"2011","journal-title":"Epilepsy. Res."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0425","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and hla-b*1502 screening in taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0430","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"Hla-b*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0435","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1081-1206(10)62997-3","article-title":"Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes","volume":"80","author":"Romano","year":"1998","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0440","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-wide association study identifies hla-a*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in japanese population","volume":"20","author":"Ozeki","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0445","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A european study of hla-b in stevens-johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0450","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pgs.10.54","article-title":"Hla-b*5901 is strongly associated with methazolamide-induced stevens-johnson syndrome\/toxic epidermal necrolysis","volume":"11","author":"Kim","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0455","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00002030-200501030-00014","article-title":"Predisposition to nevirapine hypersensitivity associated with hla- drb1*0101 and abrogated by low cd4 t-cell counts","volume":"19","author":"Martin","year":"2005","journal-title":"AIDS"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0460","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/01.aids.0000238408.82947.09","article-title":"Hla-dependent hypersensitivity to nevirapine in sardinian hiv patients","volume":"20","author":"Littera","year":"2006","journal-title":"AIDS"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0465","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0470","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0475","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between hla-b*1502 allele and antiepileptic drug-induced cutaneous reactions in han chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-11-RV-116_bb0480","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","article-title":"Hla class i markers in japanese patients with carbamazepine-induced cutaneous adverse reactions","volume":"51","author":"Ikeda","year":"2010","journal-title":"Epilepsia"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715304675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715304675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T20:57:09Z","timestamp":1686430629000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715304675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"alternative-id":["S1347436715304675"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.dmpk-11-rv-116","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}